Optimizing Propagation of Staphylococcus aureus Infecting Bacteriophage vB_SauM-phiIPLA-RODI on Staphylococcus xylosus Using Response Surface Methodology by González-Menéndez, Eva et al.
  
Article 
Optimizing Propagation of Staphylococcus aureus 
Infecting Bacteriophage vB_SauM-phiIPLA-RODI on 
Staphylococcus xylosus Using Response Surface 
Methodology 
Eva González-Menéndez 1, Francisco Noé Arroyo-López 2, Beatriz Martínez 1, Pilar 
García 1, Antonio Garrido-Fernández 2 and Ana Rodríguez 1,* 
1
 Instituto de Productos Lácteos de Asturias (IPLA-CSIC), Paseo Río Linares s/n, 33300 
Villaviciosa, Spain; eva.gm@ipla.csic.es (E.G.-M.); bmf1@ipla.csic.es (B.M.); 
pgarcia@ipla.csic.es (P.G.) 
2
 Departamento de Biotecnología de Alimentos, Instituto de la Grasa (IG-CSIC), Campus 
Universitario Pablo de Olavide, Edificio 46. Ctra, Sevilla-Utrera, 1 km, 41013 Sevilla, Spain; 
fnoe@ig.csic.es (F.N.A.-L.); garfer@cica.es (A.G.-F.) 
* Correspondence: anarguez@ipla.csic.es; Tel.: +34-985-89-21-31 (ext. 24) 
Accepted: 26 March 2018;  
Abstract: The use of bacteriophages for killing pathogenic bacteria is a feasible 
alternative to antibiotics and disinfectants. To obtain the large quantities of phages 
required for this application, large-scale production of bacteriophages must be 
optimized. This study aims to define conditions that maximize the phage yield of 
the virulent and polyvalent staphylococcal bacteriophage vB_SauM-phiIPLA-RODI 
in broth culture, using the food-grade species Staphylococcus xylosus as the host 
strain to reduce the risk of growing massive quantities of pathogenic bacteria and 
therefore, to ensure the safety of the final phage stock. The effect of four variables, 
namely initial bacterial concentration (5.66–8.40 log10 colony-forming unit 
(CFU)/mL), initial phage concentration (5–8 log10 plaque-forming unit (PFU)/mL), 
temperature (21–40 °C) and agitation (20–250 rpm), on phage yield (response) 
was studied by using response surface methodology (RSM). Successive 
experimental designs showed that agitation did not significantly impact phage 
yield, while temperature did have a significant effect, with 38 °C being the optimum 
for phage propagation. The results allowed the design of a model to describe 
phage yield as a function of the initial bacterial and phage concentrations at fixed 
agitation (135 rpm), and optimum temperature (38 °C). The maximum 
experimental phage yield obtained was 9.3 log10 PFU/mL, while that predicted by 
the model under the optimized conditions (7.07 log10 CFU/mL initial bacterial 
population and 6.00 log10 PFU/mL initial phage titer) was 9.25 ± 0.30 log10 
PFU/mL, with the desirability of 0.96. This yield is comparable to that obtained 
when the phage was propagated on the original host, Staphylococcus aureus. 
Bacteriophage phiIPLA-RODI showed the same host range and very similar biofilm 
removal ability regardless of the staphylococcal species used for its propagation. 
The results presented in this study show the suitability of using a food-grade strain 
of S. xylosus for the propagation of S. aureus infecting phages and the application 
of RSM to define the optimal propagation conditions. 
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 1. Introduction 
Staphylococcal food poisoning is one of the most common food-borne diseases 
worldwide that results from the ingestion of pre-formed enterotoxins produced by 
Staphylococcus aureus [1]. The European Food Safety Authority (EFSA) reported in 
2015 a total of 434 food-borne outbreaks caused by staphylococcal toxins [2]. In the 
United States, 352 outbreak-associated illnesses and 27 hospitalizations were 
caused by S. aureus toxins in 2016 [3]. The pathogenicity of this bacterium is due to 
a combination of toxin-mediated virulence, invasiveness and antibiotic resistance 
[4]. Indeed, methicillin-resistant S. aureus (MRSA) is one of the leading causes of 
hospital-acquired infections. 
It is also remarkable the increase in infections caused by multidrug-resistant S. 
aureus and community-associated methicillin-resistant S. aureus (CA-MRSA) as it 
results in a diminished effectiveness of the antibiotic treatment [5]. For instance, 
many methicillin-resistant strains of S. aureus (MRSA) show a decreased 
susceptibility to glycopeptides such as vancomycin [6–8]. An interesting survey 
addressed by the European Centre for Disease Prevention and Control (ECDC) in 
the period 2011–2012 showed a 41% of invasive S. aureus isolates carrying 
methicillin resistance [9]. 
Since multidrug resistance is rapidly evolving in several species including S. 
aureus [10], there is a clear need for novel approaches to circumvent this problem. 
Bacteriophages have been proposed as a suitable antimicrobial alternative to the 
use of antibiotics, as they are natural enemies of bacteria [11,12]. Currently, there is 
a renaissance of phage therapy studies in western countries, and the results from 
clinical trials in animals are confirming the efficacy of phages as therapeutics. 
Despite the regulatory hurdles, several biotechnological companies are assaying 
bacteriophages in human clinical trials to promote their future commercialization 
(reviewed by [13]). Bacteriophages are also suitable to control pathogenic bacteria 
along the food chain [14]. Several studies have demonstrated their effectiveness in 
controlling bacterial pathogens in agro-food industry, such as Salmonella, S. aureus, 
Campylobacter jejuni, Escherichia coli O157: H7, and Listeria monocytogenes [15]. 
Usefulness of bacteriophages in food safety includes their application as 
disinfectants to remove bacterial biofilms from industrial surfaces [16–18] and the 
development of tools to improve pathogen detection [19]. Since the approval of 
phage-based products to use in the food industry sector by the US FDA in 2006, 
some new bacteriophage products are commercially available. These products 
consist of a mixture of one or more bacteriophages infecting L. monocytogenes 
(PhageGuard Listex, Micreos Food Safety B.V., Wageningen, The Netherlands; 
ListShieldTM, Intralytix Inc., Baltimore, MD, USA), E. coli O157: H7 (EcoShieldTM, 
Intralytix Inc., Baltimore, MD, USA) and Salmonella (SalmoFreshTM, Intralytix Inc., 
Baltimore, MD, USA; PhageGuard S, Micreos Food Safety B.V., Wageningen, The 
Netherlands). 
We had previously isolated and characterized the S. aureus infecting phage 
vB_SauM-phiIPLA-RODI (in short, phiIPLA-RODI) that belongs to the Myoviridae 
family and exhibits a wide host range [16]. In challenge assays against S. aureus 
cultures, the phage reduced the viable counts by 5 log units in 8 h. Moreover, 
exposure of biofilms to this phage also reduced adhered bacteria by 2 log units [16]. 
Therefore, the lytic ability of phiIPLA-RODI against planktonic and sessile cells 
supports its potential as an antimicrobial to both remove staphylococcal biofilms and 
to treat S. aureus infections. 
The use of phages as antimicrobials in the clinic and the food industry requires 
large-scale and reproducible production of phage cultivation. Temperature, media 
 composition, bacteria and bacteriophage concentration are factors that can affect 
phage production [20]. 
In this regard, the aim of the present work was to optimize the propagation of 
phage phiIPLA-RODI by using a food-grade species instead of the original 
pathogenic host in a laboratory scale applying the response surface methodology 
(RSM). This methodology is a collection of mathematical and statistical techniques 
that allow the analysis of the relationship between a set of controllable experimental 
factors and the observed results of the variable of interest (response) to optimize the 
response [21,22]. Unlike the present work, the scarce studies on the production of 
bacteriophages that have already applied RSM have used the original bacterial host 
and other factors that affect phage production [23]. 
We used a food-grade strain of the species Staphylococcus xylosus as an 
alternative host to reduce the risk of growing massive quantities of a bacterial 
pathogen. The effects of different levels of the expected influential variables such as 
temperature, agitation, initial bacterial and bacteriophage concentration were 
investigated by using RSM. The equation at the region of maximum phage yield was 
validated, and a definitive model incorporating the validation data was deduced. 
Based on this model, and using the desirability approach, the optimal operating 
conditions were established. 
2. Materials and Methods 
2.1. Bacterial Strains, Bacteriophage and Media 
Staphylococcal strains were isolated in Baird-Parker (BP) agar supplemented 
with egg yolk tellurite emulsion (Scharlau, Barcelona, Spain) and routinely grown in 
Tryptic Soy Broth (TSB, Scharlau, Barcelona, Spain) with shaking (Excella E24 
Incubator Shaker, New Brunswich Scientific, Edison, NJ, USA) or Tryptic Soy Agar 
(TSA), at 37 °C. 
The food-grade strain Staphylococcus xylosus CTC1642, isolated from a 
fermented meat product (IRTA, Monells, Girona, Spain) and the strain S. aureus 
IPLA1, isolated from a dairy product (IPLA-CSIC, Villaviciosa, Asturias, Spain), were 
used to propagate the S. aureus-infecting bacteriophage phiIPLA-RODI. 
Phage titer was assessed by plaque assay. One-hundred μL of an overnight 
culture (about 109 colony-forming unit (CFU)/mL) of the host strains were mixed with 
100 μL of serial phage dilutions. These mixtures were added to 5 mL of molten TSA 
overlay (0.7% agar), poured onto TSA plates, incubated at 37 °C for 18–24 h, and 
the lysis plaques counted [16]. 
For selecting the food-grade host for phage propagation purposes, preliminary 
plaque assays with phage phiIPLA-RODI were performed on several food-grade 
strains, kindly provided by Dr Margarita Garriga (IRTA, Monells, Girona, Spain): S. 
xylosus strains (CTC1638, CTC1642 and CTC1644) and Staphylococcus carnosus 
strains (CTC6064, CTC6071 and CTC6072). The strain S. carnosus TM300, kindly 
provided by Dr Gabi Bierbaum (University of Bonn, Germany) was also tested. The 
efficiency of plating (EOP) was calculated by dividing the phage titer obtained on 
each of the tested strains by the phage titer on the reference strain S. aureus IPLA1. 
The host range of phiIPLA-RODI lysates obtained by propagation on CTC1642 
and IPLA1 was determined by plaque assay on some other staphylococcal species 
previously tested [16]. Some of them such as S. lugdunensis ZL5-11, S. pasteuri 
ZL16-6, S. arlettae ZL114-5, S. xylosus ZL61-2, S. gallinarum ZL90-5 and S. kloosii 
ZL74-2, were isolated from women’s breast milk [16], while others (S. aureus IPLA15 
 and IPLA16) were isolated from meat industry surfaces [24]. The efficiency of plating 
(EOP) of both phage lysates on each strain was calculated as indicated above. 
2.2. Biofilm Removal by Phage phiIPLA-RODI Propagated on S. xylosus CTC1642 
and S. aureus IPLA1 
Overnight cultures of S. aureus IPLA16 were diluted to 106 CFU/mL into fresh 
TSB supplemented with 0.25% glucose. Aliquots of 200 μL of each culture were 
poured into the wells of a polystyrene microtiter plate (TC Microwell 96U w/lid 
nunclon DSI plates, Thermo Scientific, Madrid, Spain). Biofilms were grown for 24 h 
at 37 °C. Wells were then washed twice with PBS buffer (137 mM NaCl, 2.7 mM 
KCl, 10 mM 138 Na2HPO4 and 2 mM KH2PO4; pH 7.4). To compare the biofilm 
degradation ability of each phage lysate, 200 μL of phiIPLA-RODI propagated on S. 
aureus IPLA1 or S. xylosus CTC1642 were added to each well (108 plaque-forming 
unit (PFU)/well). SM buffer (20 mM Tris HCl, 10 mM of MgSO4, 10 mM of Ca(NO3)2 
and 0.1 M of NaCl, pH 7.5) was added for control purposes. The microwell plates 
were incubated for 4 h at 37 °C. The supernatants were removed, and wells washed 
once with SM buffer (20 mM Tris HCl, 10 mM MgSO4, 10 mM Ca(NO3)2 and 0.1 M 
NaCl, pH 7.5) and air-dried for 15 min at room temperature. The biomass adhered 
to the wells was determined by crystal violet (0.1%, w/v) staining as described 
previously [25]. All the assays were performed using three biological replicates. 
2.3. One-Step Growth Curve 
One-step growth curve assays were carried out with phage phiIPLA-RODI, using 
the sensitive strains S. aureus IPLA1 and S. xylosus CTC1642. A standardised 
protocol, previously described [26], was adapted for this study. 
Curves were performed in TSB supplemented with Ca(NO3)2 (10 mmol L
−1) and 
MgSO4 (10 mmol L
−1) using a multiplicity of infection (MOI) of 0.01. 
Mid-exponential-phase cultures (10 mL) of S. aureus IPLA1 and S. xylosus 
CTC1642 (OD600 = 0.1) were collected by centrifugation and suspended into 1 mL of 
fresh TSB. The phage was added and allowed to adsorb for 5 min at 37 °C with 
shaking. The mixture was then centrifuged, pelleted cells resuspended in 10 mL of 
TSB, and incubation continued at 37 °C. Samples were first taken at 5 min intervals 
for 30 min, and subsequently at 10 min intervals. Each sample was immediately 
diluted and plated for phage titration. 
2.4. Bacteriophage Amplification: Conventional Phage Propagation 
Bacteriophage phiIPLA-RODI was routinely propagated on S. aureus IPLA1 
and S. xylosus CTC1642, according to the following procedure: TSB broth was 
inoculated with 1% (v/v) inoculum of an overnight culture of the strains indicated 
above, and incubated at 37 °C with shaking until an OD600 = 0.1 (10
7 CFU/mL) was 
reached. Phage was added to the bacterial culture at MOI of 1.0 and incubation 
proceeded for a further 3.5 h at 37 °C with shaking. Phage preparations were 
obtained by centrifugation and further filtration to remove bacterial cells and debris. 
The phage titer was determined by the plaque assay using 100 µL of an S. 
aureus IPLA1 overnight culture as a host, and 100 µL of the phage dilution. This 
mixture was added to 5 mL of molten TSA overlay (0.7% agar) and poured onto TSA 
plates and incubated at 37 °C for 18–24 h [16]. 
2.5. Bacteriophage Amplification: Phage Propagation for Optimization Purposes 
 Frozen stocks (−80 °C) of the strain S. xylosus CTC1642 (about 108 CFU/mL) 
were quickly thawed and used to inoculate at different concentrations (CFU/mL) in 
50 mL Falcon tubes filled with 10 mL of TSB broth. The actual viable cell counts 
were determined immediately after inoculation by plating decimal dilutions of 
samples onto TSA. 
For phage propagation, cultures were infected with different concentrations 
(PFU/mL) of phage phiIPLA-RODI. The combined effect of initial phage titer, initial 
host concentration, temperature, and agitation on phage yield (final phage titer) and 
phage amplification ratio (estimated as the difference between final phage titer and 
the initial phage titer, expressed in log10 values) was evaluated after 3.5 h of 
incubation. The phage titer was determined as described in the previous section. 
2.6. Experimental Design 
The assays consisted of three successive designs that allowed estimating the 
effects of four independent continuous variables (initial phage titer, initial bacterial 
concentration, temperature, and agitation) on the phage yield and optimizing the 
conditions that could eventually result in the highest phage yield. The first design 
was used for an initial exploration of the experimental region in which phage 
production was expected to occur. It consisted of a quadratic Central Composite 
Design with the following ranges of the variables: initial phage titer (5.00 to 8.00 
log10 PFU/mL); initial bacterial concentration (6.0 to 8.0 log10 CFU/mL); temperature 
(21 to 37 °C) and agitation (20 to 250 rpm). The objective of the second design was 
focused on the effect of temperature, using a D-optimal design, at fixed agitation 
(135 rpm). It had the following ranges for the variables: initial phage titer (6.0 to 8.0 
log10 PFU/mL); initial bacterial concentration (5.0 to 7.0 log10 CFU/mL) and 
temperature (34 to 40 °C). Finally, the third design aimed at developing a Response 
Surface equation, using Central Composite Design, to predict phage production in 
the region of highest yield. It included only the initial phage titer (5.79 to 7.21 log10 
PFU/mL) and initial bacterial concentration (5.59 to 8.41 log10 CFU/mL), while 
temperature and agitation were fixed at 38 °C and 135 rpm, respectively. The 
characteristics of these designs (and their respective yields) are summarized in 
Table 1.The levels of variables for all the designs were given by the program 
Design-Expert software version 7.0 (State-Ease, Inc., Minneapolis, MN, USA), 
provided their ranges and type of design. The order of the run performance was 
always randomly chosen. However, the values for initial bacterial populations, 
although intended to be those proposed by the designs, were difficult to fix 
accurately. Therefore, the actual bacterial concentrations reached just after 
inoculation, as determined by viable cell counts, were used for the statistical 
analysis. 
 Table 1. Experimental designs used for optimizing the phage yield (response) as a function of temperature, initial bacterial concentration, initial 
phage titer and agitation. Responses are also included. 
 1st Tentative Design (Central Composite) 2nd Design (D-Optimal) 
a
 
3rd Design (Central 
Composite) 
b
 
Run
s 
Phag
e 
Titer 
Bacterial 
Concentratio
n 
Temperatur
e (°C) 
Agitatio
n (rpm) 
Phag
e 
Yield 
Phag
e 
Titer 
Bacterial 
Concentratio
n 
Temperatur
e (°C) 
Phag
e 
Yield 
Phag
e 
Titer 
Bacterial 
Concentratio
n 
Phag
e 
Yield 
1 7.39 7.56 24.2 67 5.53 8.00 5.78 40.0 7.42 7.00 6.85 8.4 
2 6.50 7.28 29.0 135 5.67 6.00 5.95 34.0 6.61 6.50 7.72 9.0 
3 6.50 8.27 29.0 135 4.37 7.19 7.45 37.6 8.43 6.50 7.35 9.3 
4 5.61 6.96 33.8 67. 6.66 7.19 6.30 34.0 6.86 6.50 6.05 8.5 
5 5.00 7.53 29.0 135 4.86 6.00 7.44 34.0 7.57 7.21 7.61 8.9 
6 5.61 7.99 33.8 203 4.08 7.18 6.48 37.8 7.37 5.79 7.41 9.1 
7 6.50 7.51 29.0 135 5.79 8.00 6.81 40.0 7.81 6.00 8.15 3.7 
8 6.50 7.62 29.0 135 6.00 8.00 5.66 36.1 8.27 7.00 8.11 8.3 
9 6.50 7.38 21.0 135 5.51 6.00 6.66 37.6 8.05 6.50 7.61 9.0 
10 6.50 6.25 29.0 135 6.13 6.00 7.82 40.0 8.12 6.50 7.34 9.0 
11 6.50 7.57 29.0 135 5.68 6.00 7.43 40.0 8.27 6.00 6.29 8.7 
12 8.00 7.11 29.0 135 6.80 8.00 7.48 34.0 8.04 6.50 7.53 9.1 
13 5.61 7.88 24.2 203 4.23 6.00 5.77 34.0 7.58 6.50 8.40 4.1 
14 7.39 7.01 24.2 203 7.06 6.70 5.86 40.0 7.54    
15 5.61 6.99 24.2 67 5.25        
16 6.50 7.04 29.0 20 5.02        
17 6.50 7.11 29.0 135 5.26        
18 6.50 6.85 37.0 135 8.13        
19 7.39 7.15 33.8 203 7.34        
20 7.39 7.70 33.8 67 6.83        
21 6.50 7.18 29.0 250 6.43        
Note: Phage titer and phage yield are expressed as log10 plaque-forming unit (PFU)/mL and bacterial concentration is expressed as log10 
colony-forming unit (CFU)/mL. The bacterial concentrations correspond to the effective levels reached in the experiment. Standard deviations for the 
design values (as estimated from the analysis of variance (ANOVA) pure error) were 0.34, 0.14, 0.13 log10 PFU/mL, respectively. 
a,b
 Agitation fixed 
at 135 rpm. 
b
 Temperature fixed at 38 °C. 
 2.7. Analysis of Results, Model Validation, and Final Response Surface (RS) 
Equation 
The effects of the above-indicated variables (factors) on phage propagation 
(initial phage titer (A), initial bacterial concentration (B), temperature (C) and 
agitation (D)) were analyzed by the response surface methodology (RSM), using the 
following general quadratic model: 
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where k was 4, 3 and 2 for first, second, and third design, respectively [27]. The 
significant influential variables were those suggested by the sequential sum of 
squares (Type I) and supported by the corresponding ANOVA (partial sum of 
squares type III). The final models were obtained by a stepwise process, using p ≤ 
0.05 and p ≥ 0.10 as criteria for entering and removal of variables, respectively. The 
effects of the variables and model fits were also checked graphically. For the 
validation of the third model, nine additional assays were performed with the initial 
phage titer fixed at 6.5 log10 PFU/mL and the initial bacterial populations around the 
levels of maximal phage yield. A final equation for the model was developed by 
enlarging the data from the third design with the validation results. This last model 
was used for obtaining the conditions which maximize the phage yield and 
amplification. 
2.8. Statistical Analysis 
Statistical analyses for phage propagation were performed using the statistical 
package IBM SPSS Statistics for Windows Version 23 (IBM Corp. Armonk, NY, 
USA). Data related to phage propagation carried out with the control host (S. aureus 
IPLA1), and test host (S. xylosus CTC1642) were subjected to one-way ANOVA, 
and the Student-Newman-Keuls (SNK) test was used for comparison of means at a 
level of significance p < 0.05. Three biological replicates were used in all the 
assays. 
For optimizing the phage propagation on S. xylosus CTC1642, the experiments 
were always designed and analyzed using Design-Expert software version 7.0 
(State-Ease, Inc., Minneapolis, MN, USA). Final optimization was achieved using 
the desirability approach, which finds operating conditions that provide the “most 
desirable” response values. The desirability function di (Yi) assigns numbers 
between 0 (undesirable value) and 1 (ideal response) to the possible values of Yi 
(phage yield or phage amplification ratio). Usually, the individual desirability values 
are combined using the geometric mean, which gives the overall desirability (D) 
which is maximized with respect to the controlled variables. 
3. Results 
3.1. PhiIPLA-RODI Infects Food-Grade S. xylosus Strains and Other Staphylococcal 
Species 
To avoid amplification of virulence genes or the risk of accidental contamination 
with the original host (S. aureus), the ability of phage phiIPLA-RODI to infect 
food-grade staphylococcal strains was tested. The sensitivity of three S. xylosus and 
four S. carnosus strains was determined by the plaque assay, and the efficiency of 
plating (EOP) was also calculated. The EOP was determined by comparison to the 
 reference strain S. aureus IPLA1. None of the S. carnosus strains and S. xylosus 
CTC1638 was sensitive to the phage. By contrast, EOP values of 0.31 and 0.00004 
were obtained for S. xylosus CTC1642 and S. xylosus CTC1644, respectively. 
According to these results, S. xylosus CTC1642 was selected as a potential host for 
further phage propagation. 
One-step growth curves of phage phiIPLA-RODI, pre-amplified on S. aureus 
IPLA1, were obtained on both S. aureus IPLA1 and S. xylosus CTC1642 (Figure 1). 
Values of burst size (number of viral particles per infected cell) determined at 60 min 
after infection were 25 and 10, respectively. 
 
Figure 1. One-step growth curves of phiIPLA-RODI on S. aureus IPLA1 (black diamonds) 
and S. xylosus CTC1642 (grey squares), respectively. Values correspond to the number of 
plaque-forming unit (PFU) per infected cell. Each data point shows the mean ± standard 
deviation for three independent experiments. 
Data of phage phiIPLA-RODI propagation on S. aureus IPLA1 were compared 
with those obtained on S. xylosus CTC1642 under the same experimental conditions 
used in conventional phage propagation, as explained in M&M section. The titer of 
lysates obtained using S. aureus IPLA1 as a host strain (8.9 ± 0.1 log10 PFU/mL) was 
significantly higher (p < 0.05) than the value of suspensions propagated on S. 
xylosus (8.2 ± 0.2 log10 PFU/mL). 
Regardless of the staphylococcal species used for phage propagation, 
phiIPLA-RODI showed the same host range and similar EOPs on the different 
Staphylococcus species tested (Table S1). In addition, the phage propagation on 
IPLA1 and CTC1642 strains did not result in any significant differences in its biofilm 
removal ability (Figure S1). 
3.2. Identification of Experimental Factors Affecting Phage Yield 
The first experimental design consisted of 21 propagation runs which included 
the four experimental factors (A: initial phage titer, B: initial bacterial concentration, 
C: temperature and D: agitation) expected to influence the phage yield (Table 1). 
The levels used were those proposed by the software (except for bacteria which 
concentrations were those effectively reached in the experiment as commented 
above). The phage yield responses were analyzed by the sequential model sum of 
squares and the fit subjected to the corresponding ANOVA. From the analysis (Table 
2), it was deduced that the effect of agitation on the phage yield was not significant (p 
 > 0.05) in the range of 20–250 rpm (i.e., it was not retained). On the contrary, the 
initial phage titer and temperature showed significant (at p < 0.05) linear effects while 
the initial bacterial concentration had a significant (at p ≤ 0.10) quadratic effect. The 
retention of the non-significant linear term of the initial bacterial population is due to 
the application of the hierarchical principle, which establishes the maintenance of 
lower order term (linear in this case) when one of higher order is retained (Table 2). 
These effects are shown graphically in Figure 2 as functions of several variables. 
Regardless of the initial bacterial population, an increase in the initial phage titer, 
within the ranges studied in this case, always led to a higher phage yield (Figure 2A). 
Also, a linear increase of the phage yield was observed as the temperature rose 
(Figure 2B). Moreover, as the initial population of bacteria and temperature 
increased, there were a progressive (quadratic) decrease and a linear increment of 
phage yield, respectively (Figure 2B,C). 
  
 Table 2. ANOVA for Response Surface Reduced Quadratic Model (partial sum of squares 
type III) of the first design. 
Source 
Sum of 
Squares 
Degrees of 
Freedom 
Mean 
Square 
F 
Value 
p-Value (Prob > 
F) 
Model 16.99 4 4.25 12.45 
<0.0001 
significant 
A-Phage 4.46 1 4.46 13.09 0.0023 
B-Bacteria 0.78 1 0.78 2.28 0.1508 
C-Temperature 3.62 1 3.62 10.62 0.0049 
B
2
 1.21 1 1.21 3.56 0.0775 
Residual 5.46 16 0.34   
Cor total 22.44 20    
Notes: The term B-Bacteria, was introduced in application of the hierarchical principle. Alfa 
to enter, p ≤ 0.05, alfa to exit, p ≥ 0.10. 
 
Figure 2. Plot of the first design response. Phage yield (response) as a function of: initial 
phage titer at fixed temperature (33.76 °C) and agitation (135 rpm) for two levels of bacteria 
(A); temperature at fixed initial phage titer (6.74 log10 PFU/mL), initial bacterial 
concentration (7.00 log10 CFU/mL) and agitation (135 rpm) (B); and initial bacterial 
concentration at fixed initial phage titer (6.43 log10 PFU/mL) and agitation (135 rpm) for two 
temperature levels (C). 
Therefore, a new design was performed in which the agitation was fixed at an 
intermediate level (135 rpm) since its effect on phage yield was not significant (p > 
 0.05). On the contrary, the temperature was increased to the range 34–40 °C, due to 
the favorable linear effects previously observed (Figure 2B). Finally, the ranges of 
the initial phage and bacterial concentration were fixed from 6.00 to 8.00 log10 
PFU/mL and from 5.00 to 7.00 log10 CFU/mL respectively, to include the 
experimental regions of high phage yield.  
In these conditions, the effect of the initial phage concentration was not 
significant but the temperature had a significant quadratic effect (Table 3), 
regardless of the concentration of the initial bacterial population, and showed a clear 
optimum around 38 °C (Figure 3). As in the first design, the effect of the initial 
bacterial population on the phage yield was also quadratic and significant at p ≤ 0.10 
(Table 3) with a high initial bacterial population resulting in a lower phage yield 
(Figure 3), regardless of temperature. Hence, the most relevant conclusion of this 
design was the quadratic effect of temperature and the identification of the level for 
maximum phage yield. 
Table 3. ANOVA for Response Surface Reduced Quadratic Model (partial sum of squares 
type III) of the second design. 
Source 
Sum of 
Squares 
Degrees of 
Freedom 
Mean 
Square 
F 
Value 
p-Value Prob > 
F 
Model 2.51 4 0.63 4.59 0.0271 
B-Bacteria 0.13 1 0.13 0.91 0.3644 
C-Temperature 0.30 1 0.30 2.19 0.1734 
B
2
 0.52 1 0.52 3.76 0.0844 
C
2
 0.86 1 0.86 6.28 0.0336 
Residual 1.23 9 0.14   
Cor total 3.75 13    
Notes: The term B-Bacteria and C-Temperature were introduced in application of the 
hierarchical principle. Alfa to enter, p ≤ 0.05, alfa to exit, p ≥ 0.10. 
 
Figure 3. Plot of the second design response. Phage yield (response) as a function of 
temperature, at two initial bacterial concentrations, and fixed initial phage titer (7.32 log10 
PFU/mL). 
3.3. Response Surface Model for Phage phiIPLA-RODI Yield 
The results from the previous design led to planning a third one in which 
temperature was fixed at its optimum (38 °C) and agitation at 135 rpm, while the 
 ranges of phage and bacteria were maintained similar (Table 1, third design). 
However, as commented above, the design levels for the theoretical initial bacterial 
concentrations were difficult to reach and resulted in the actual values included in 
Table 1, which were used for the statistical analysis. The analysis of this design 
revealed, within the ranges of the variables assayed, a non-significant effect of initial 
phage titer and a persistent quadratic significant effect of the initial bacterial 
population (Table 4). The equation had the following expression: 
 
            (     
   
  ⁄ )                                     
  (1) 
Table 4. ANOVA for Response Surface Reduced Quadratic Model (partial sum of squares 
type III) of the third design. 
Source 
Sum of 
Squares 
Degrees of 
Freedom 
Mean 
Square 
F 
Value 
p-Value Prob > F 
Model 37.26 2 18.63 20.01 <0.0001 significant 
B-Bacteria 2.15 1 2.15 2.30 0.1455 
B
2
 18.16 1 18.16 19.50 0.0003 
Residual 1.04 18 0.058 
  
Lack of fit 0.78 16 0.049 0.37 
0.9042 not 
significant 
Pure error 0.26 2 0.13   
Cor total 4.03 19    
Notes: The term B-Bacteria was introduced in application of the hierarchical principle. Alfa 
to enter, p ≤ 0.05, alfa to exit, p ≥ 0.10. 
The model showed a significant fit and an insignificant lack of fit (Table 4). The 
response surface plot of the equation (Figure 4) was a plane with a slightly rising hill 
which reached its maximum at an initial bacterial concentration of 6.82 CFU/mL. 
Then, it decreased sharply at higher bacterial concentrations because of the 
negative sign and quadratic exponent of this variable (Equation (1)). Moreover, the 
phage titer has been particularly high in some experiments with up to 9.3 log10 
PFU/mL (Table 1), the highest titer found so far. That is, the third design pointed to 
combinations of the variables which resulted in maximum response (Figure 4), due 
to the Equation (1) structure. 
 
  
Figure 4. Response surface plot of phage yield as a function of the initial bacterial 
population and phage titer, based on the experiments from the third design, with a 
maximum at 6.82 log10 CFU/mL initial bacteria. 
3.4. Validation of RSM 
Once reached the region of maximum phage production, nine validation 
experiments were performed at the levels specified in Table 5. There were no 
differences between the experimentally observed and predicted values. Therefore, 
the model (Equation (1)) could be used to make predictions. 
Table 5. Experimental conditions, predicted responses (±SE) according to the RS model 
developed for the 3rd experimental design, and actual results for the validation 
experiments. 
Initial 
Bacteria 
Population 
Initial 
Phage 
Titer 
Phage Yield, 
Validation 
Experiments 
Predicted Phage 
Yield, RS 3rd 
Design 
Predicted Phage 
Yield, RS Enlarged 
3rd Design 
a
 
7.51 6.50 8.8 ± 0.1 8.6 ± 0.5 8.7 ± 0.3 
7.42 6.50 8.8 ± 0.1 8.7 ± 0.5 8.8 ± 0.3 
7.63 6.50 8.8 ± 0.1 8.3 ± 0.5 8.4 ± 0.3 
7.56 6.50 8.7 ± 0.1 8.5 ± 0.5 8.5 ± 0.3 
7.72 6.50 8.8 ± 0.1 8.1 ± 0.5 8.2 ± 0.3 
7.62 6.50 8.8 ± 0.1 8.3 ± 0.5 8.4 ± 0.3 
7.35 6.50 8.6 ± 0.1 8.9 ± 0.5 8.9 ± 0.3 
7.28 6.50 8.5 ± 0.1 9.0 ± 0.5 9.0 ± 0.3 
7.39 6.50 8.8 ± 0.1 8.8 ± 0.5 8.9 ± 0.3 
Note: bacteria and phage populations are expressed as log10 CFU/mL and 1og10PFU/mL, 
respectively. 
a
 Predicted responses (±SE) based on the final Response Surface including 
the validation data. 
3.5. Final Equations for the Phage Production and Phage Amplification Ratio 
The results from the third experimental design were enlarged with those 
obtained in the validation tests. The new data set was then used to estimate a 
definitive RS from a higher number of responses and degrees of freedom. The 
model estimated was, as in the case of the third design, a quadratic function of the 
initial bacterial concentration which also retained the linear term to preserve the 
 hierarchical principle (Table 6). Its equation, expressed in terms of the physical 
variable units, was the following: 
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  (2) 
 
where bacteria is the initial bacterial concentration in the culture medium, expressed 
in log10 CFU/mL. The Equation (2) was quite similar to that obtained when using only 
the data from the third design (Equation (1)) and also reached the maximum at a 
very close initial bacterial concentration (6.85 vs. 6.82 log10 CFU/mL). The predicted 
phage yields for the validation data using this final equation were similar to those 
deduced previously from the third design, but the predictions had a lower dispersion 
(0.5 vs. 0.3 SE) (Table 5, last two columns). 
 
Table 6. ANOVA for Response Surface Reduced Quadratic Model (partial sum of squares 
type III) based on the data from the third design and the validation data. 
Source 
Sum of 
Squares 
Degrees of 
Freedom 
Mean 
Square 
F 
Value 
p-Value Prob > F 
Model 37.26 2 18.63 20.01 <0.0001 significant 
B-Bacteria 2.15 1 2.15 2.30 0.1455 
B
2
 18.16 1 18.16 19.50 0.0003 
Residual 1.04 18 0.058 
  
Lack of fit 0.78 16 0.049 0.37 
0.9042 not 
significant 
Pure error 0.26 2 0.13   
Cor total 4.03 19    
Notes: The term B-Bacteria was introduced in application of the hierarchical principle. Alfa 
to enter, p ≤ 0.05, alfa to exit, p ≥ 0.10. 
After optimization, propagation of phiIPLA-RODI on S. xylosus CTC1642 
reached an average titer of 8.9 ± 0.1 log10 PFU/mL, which was not significantly 
different from that obtained with the reference strain of S. aureus IPLA1 (8.9 ± 0.2 
log10 PFU/mL) (p > 0.05). 
However, not only the phage yield is important but also the phage amplification 
ratio (i.e., the times the phage population (expressed in log10) is multiplied during the 
propagation process). The RS model estimated was also significant, had a 
non-significant lack of fit (Equation (3)), and was quite similar to that previously 
deduced for phage yield (Equation (2). It took the following form: 
                                                               (3) 
 
Mathematically, regardless of the initial phage population, the optimum phage 
amplification ratio (or population multiplication) is also situated at bacterial 
concentrations around 6.8 log10 CFU/mL (18.63/2 × 1.37, since the first derivative at 
the maximum, should be null). However, it may also be obtained considering the 
initial bacteria and phage titer simultaneously. With this objective, the desirability 
approach was applied, using the following criteria: initial bacterial concentration 
within the range 6–9 log10 CFU/mL, minimum initial phage titer in the range 6–8 log10 
PFU/mL, maximum phage yield and phage amplification ratio. The results indicated 
that, by using initial bacterial and phage concentrations of about 7.07 log10 CFU/mL 
and 6.00 log10 PFU/mL, respectively, a remarkable phage yield (9.25 ± 0.9 log10 
 PFU/mL) and phage amplification ratio (2.72 ± 0.90) could be obtained (Figure 5), 
with a total desirability of 0.96 (quite close to the ideal value of 1.00). Therefore, the 
process may reach the highest phage yield and, at the same time, maximum 
amplification (the initial phage is increased by almost 3 log units). 
 
Figure 5. Optimization of both final phage yield and phage multiplication ratio. Final phage 
yield ( ) and phage multiplication ratio ( ), as a function of initial bacterial populations ( ) and 
phage titers ( ), using the desirability approach as implemented in Design Expert. 
4. Discussion 
To exploit the advantages of bacteriophages as antimicrobials, it is essential to 
adapt their production to meet quality and safety requirements for sustainable phage 
therapy products [28]. In this context, the use of a surrogate host such as a 
food-grade bacterium minimizes the risk of toxin or host contamination on phage 
preparations. The ability of phage phiIPLA-RODI to infect a wide spectrum of 
staphylococcal strains [16] allowed selecting a S. xylosus strain, from meat origin, to 
propagate the phage. A reduction in the phage yield (final phage titer) could be 
expected due to the lower burst size calculated in S. xylosus compared with S. 
aureus (10 versus 25 phage particles per infected cell). In this regard, a reduction in 
the burst size was also observed when the Salmonella phage phi PVP-SE3 was 
propagated in the non-pathogenic strain E. coli BL21 [29], while a similar number of 
phage particles per infected cell were obtained after infection of S. xylosus by the S. 
aureus infecting phage Team1 [30]. As previously observed in other phages [30], the 
host range and the EOP value shown by phiIPLA-RODI when propagated on both S. 
xylosus CTC1642 and S. aureus IPLA1 were fairly similar. Besides, the ability of 
phiIPLA-RODI to remove biofilms was similar regardless of the bacterial host used 
for phage propagation. Overall, the lack of pathogenicity of the host strain S. xylosus 
CTC1642 and consequently, the safety of the final phage product justify, in our 
opinion, the use of the food-grade strain even though a lower phage yield is 
obtained. In an attempt to counteract this disadvantage, we optimized the 
phiIPLA-RODI propagation process by using RSM since it is handy for studying 
processes in which the response is influenced by several variables [22]. In fact, this 
method was previously used to optimize the production of an E. coli infecting 
filamentous phage [23]. It should be noticed, however, that filamentous phages do 
not reproduce by lysing bacteria, instead, they are secreted into the environment 
without killing the host, while the life cycle of myovirus phages ends with the lysis of 
the host. Likewise, Grieco et al. [23] have used temperature, dissolved oxygen and 
 pH as independent variables while, in our study, phage and bacterial concentration, 
temperature and agitation were tentatively considered initial influential on the phage 
yield when S. xylosus is used as propagation host. Remarkably, the initial bacterial 
concentration was particularly significant for phiIPLA-RODI propagation as it had a 
quadratic effect on the phage yield. 
The propagation process is the result of a succession of several infection cycles, 
and each of them consists of an adsorption period, nucleic acid uptake, latent period 
and progeny release. The duration of these steps and the number of phage particles 
produced per infected cell will determine the phage yield [31,32]. It is well known that 
phage-host interactions are affected by environmental conditions that alter the 
physiological state of bacteria, through changing their susceptibility to phage 
infection and the phage productivity [33]. Moreover, optimal bacteriophage infection 
traditionally requires bacterial host growing exponentially, although some 
bacteriophages like T4 can efficiently infect E. coli in stationary phase and kill the 
host after a hibernation period [34]. 
In this context, a first design was used as initial guidance for approaching the 
production of phages in an experimental region (space limited by the range of 
variables) in which, according to previous non-systematic assays, high phage yield 
(response) were expected. The results showed that agitation within the range 
assayed did not affect phage yield, however, agitation might favor the encounter 
between bacteria and phage needed for the phage infection to take place and 
prevent the bacterial cell from sedimentation. Therefore, the use of an intermediate 
level (135 rpm) was fixed for further assays. For the variable temperature, a wide 
range of 21–37 °C was initially selected to include values even lower than the 
optimal for Staphylococcus growth because other authors have previously observed 
improved phage production at temperatures below the optimum for bacterial host 
growth [23]. The data from the assays proposed by the first design pointed out that 
the range of temperature was not appropriate since the effect on the phage yield was 
linear and increased progressively as the temperature rose. Therefore, these results 
supported the notion of using a higher temperature around those that favor host 
metabolism for additional designs. The linear effect of initial phage titer and the 
quadratic effect of the initial bacterial concentration on the phage yield also 
suggested to increase the initial phage concentration and to decrease the initial 
bacteria concentration. Hence, the analysis of the data from the experiments 
proposed by the first design reduced the influential variables to three: initial phage 
titer, initial bacterial concentration and temperature. 
Subsequently, the main goal of the second design was exploring the effect of 
temperature in detail, covering the region of optimal host growth and, eventually, the 
optimum level of phage yield. Its results confirmed the pertinence of increasing 
temperature and showed a quadratic effect defining the optimum temperature at 38 
°C that was adopted for further assays. The range of the initial bacterial population 
was still appropriate, and the ANOVA led to the identification of a quadratic effect (p 
≤ 0.10) for this variable, in agreement with the results of the first design. The effect of 
initial phage concentration was not statistically significant under the experimental 
conditions proposed by the second design. The reason for this observation could be 
the different ranges of temperature tested. Indeed, it is well known that the lytic 
phage infection process is very much dependent on the bacterial host metabolic 
machinery. Therefore, a temperature that improves bacterial metabolic activity will 
result in a better phage yield. In this regard, it should be noted that the range used in 
the second design (34–40 °C) is more appropriate for the bacterial host growth than 
that used in the first design (21–37 °C), resulting in an enhanced phage yield and 
 consequently, the initial phage concentration has not longer statistically significant 
effect on the response. 
Once the optimum temperature was defined, the influential variables were 
reduced to only two: initial phage titer and bacterial concentration. Further analysis 
of the relationship between these variables was approached by the third design in 
which the interest was focused on finding the equation of the RS defining the region 
of maximum phage production, already outlined from the results of the previous 
design. The ranges of both variables were established taking into account that, for 
an efficient infection process, phages should be able to encounter the bacterial cell 
host. For this purpose, the bacterial population must exceed its proliferation 
threshold [35,36], to facilitate the initial phage titer to increase. It should be noticed 
that MOI (as phage/bacteria ratio) has not been used as independent variable in the 
current study because similar MOI values are obtained from different concentrations 
of initial phage and bacteria. In fact, the particular phage and bacteria concentrations 
used for phage propagation did really result in different values of the final phage titer. 
Having fixed agitation and temperature, the data from the experimental assays of the 
third design confirmed the quadratic effect of bacteria regardless of the initial phage 
titer, which was not significant within the studied range. All the parameters related to 
the model fit were appropriate. In addition, several independent validation 
experiments showed also good agreement with its predictions and, remarkably, the 
incorporation of validation data into those from the third model allowed deducing a 
final RS model with a higher degree of freedom for the medium standard error (MSE) 
and narrower confidence limits for the estimations. Also, from the third model, 
enlarged with the validation data, a final model could be deduced which led not only 
to the conditions of optimal phage production but also revealed a sharp decrease in 
the phage yield at bacterial concentrations above 7.5 log10 CFU/mL. This behavior 
could be due to the adsorption of a proportion of the new viral progeny to the host 
cells that were not initially infected, which could partially hamper its detection by 
phage titration. 
The optimization process allowed therefore maximizing the phage yield and the 
phage amplification ratio, while minimizing the initial phage concentration and using 
an initial bacterial population between the ranges studied in the third design. The 
optimization process deduced several possible combinations. Among them, it was 
chosen that providing the highest desirability which consisted of the initial bacterial 
population, 7.07 log10 CFU/mL; and initial phage titer, 6.00 log10 PFU/mL (Figure 5), 
while maintaining agitation (135 rpm) and temperature (38 °C) at their fixed levels. 
Using these conditions, it is expected a phage yield of up to 9.25 ± 0.35 log10 
CFU/mL along with a phage amplification ratio of 2.72 log units over the initial phage 
titer. The global desirability, defined as the geometric mean of desirability values of 
the phage yield and phage amplification ratio, would be in this case high (0.96) and 
fairly close to the most “desirable” response 1.00. These results support the use of 
the food-grade strain S. xylosus CTC1642 as an appropriate alternative of the 
pathogenic strain S. aureus IPLA1 for phiIPLA-RODI propagation at the setting 
conditions established by the final RS model. The setting parameters could be the 
starting point for performing the upscaled production of the phage that would be 
required for its potential use in clinical [28] and food safety [15] applications. 
Supplementary Materials: Supplementary materials can be found at 
www.mdpi.com/link. 
Acknowledgments: This research study was supported by grants 
AGL2015-65673-R (Ministry of Science and Innovation, Spain), GRUPIN14-139 
 (Program of Science, Technology and Innovation 2013–2017 and FEDER EU funds, 
Principado de Asturias, Spain). FNAL thanks a Ramón y Cajal contract. PG, BM, and 
AR are members of the FWO Vlaanderen funded “Phagebiotics” research 
community (WO.016.14) and the bacteriophage network FAGOMA II. 
Author Contributions: Eva González-Menéndez, Francisco Noé Arroyo-López, 
Beatriz Martínez, Pilar García, Antonio Garrido-Fernández and Ana Rodríguez 
conceived and designed the experiments; and Eva González-Menéndez performed 
the experiments; Eva González-Menéndez, Francisco Noé Arroyo-López, Antonio 
Garrido-Fernández and Ana Rodríguez analyzed the data; Eva 
González-Menéndez, Francisco Noé Arroyo-López, Beatriz Martínez, Pilar García, 
Antonio Garrido-Fernández and Ana Rodríguez wrote the paper. 
Conflicts of Interest: The authors declare no conflict of interest. The founding 
sponsors had no role in the design of the study; in the collection, analyses, or 
interpretation of data; in the writing of the manuscript, and in the decision to publish 
the results. 
References 
1. Hennekinne, J.A.; de Buyser, M.L.; Dragacci, S. Staphylococcus aureus and its 
food poisoning toxins: Characterization and outbreak investigation. FEMS 
Microbiol. Rev. 2012, 36, 815–836, doi:10.1111/j.1574-6976.2011.00311.x. 
2. European Food Safety Authority (EFSA); European Centre for Disease 
Prevention and Control (ECDC). The European Union summary report on trends 
and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2015. 
EFSA J. 2016, 14, 4634, doi:10.2903/j.efsa.2016.4634. 
3. Centers for Disease Control and Prevention (CDC). National Outbreak 
Reporting System (NORS); Centers for Disease Control and Prevention (CDC): 
Atlanta, GA, USA, 2017. 
4. Le Loir, Y.; Baron, F.; Gautier, M. Staphylococcus aureus and food poisoning. 
Genet. Mol. Res. 2003, 2, 63–76. 
5. Davis, S.L.; Perri, M.B.; Donabedian, S.M.; Manierski, C.; Singh, A.; Vager, D.; 
Haque, N.Z.; Speirs, K.; Muder, R.R.; Robinson-Dunn, B.; et al. Epidemiology 
and outcomes of community-associated methicillin-resistant Staphylococcus 
aureus infection. J. Clin. Microbiol. 2007, 45, 1705–1711, 
doi:10.1128/JCM.02311-06. 
6. Enright, M.C.; Robinson, D.A.; Randle, G.; Feil, E.J.; Grundmann, H.; Spratt, 
B.G. The evolutionary history of methicillin-resistant Staphylococcus aureus 
(MRSA). Proc. Natl. Acad. Sci. USA 2002, 99, 7687–7692, 
doi:10.1073/pnas.122108599. 
7. Loomba, P.S.; Taneja, J.; Mishra, B. Methicillin and vancomycin resistant S. 
aureus in hospitalized patients. J. Glob. Infect. Dis. 2010, 2, 275–283, 
doi:10.4103/0974-777X.68535. 
8. Tarai, B.; Das, P.; Kumar, D. Recurrent challenges for clinicians: Emergence of 
methicillin-resistant Staphylococcus aureus, vancomycin resistance, and current 
treatment options. J. Lab. Physicians 2013, 5, 71–78, 
doi:10.4103/0974-2727.119843. 
9. European Centre for Disease Prevention and Control (ECDC). Point Prevalence 
Survey of Healthcare-Associated Infections and Antimicrobial Use in European 
Acute Care Hospitals; European Centre for Disease Prevention and Control 
(ECDC): Stockholm, Sweden, 2013. 
 10. Munita, J.M.; Bayer, A.S.; Arias, C.A. Evolving resistance among Gram-positive 
pathogens. Clin. Infect. Dis. 2015, 61 (Suppl. 2), S48–S57, 
doi:10.1093/cid/civ523. 
11. Kutter, E.; De Vos, D.; Gvasalia, G.; Alavidze, Z.; Gogokhia, L.; Kuhl, S.; 
Abedon, S.T. Phage therapy in clinical practice: Treatment of human infections. 
Curr. Pharm. Biotechnol. 2010, 11, 69–86. 
12. Cooper, C.J.; Khan Mirzaei, M.; Nilsson, A.S. Adapting drug approval pathways 
for bacteriophage-based therapeutics. Front. Microbiol. 2016, 7, 1209, 
doi:10.3389/fmicb.2016.01209. 
13. Vandenheuvel, D.; Lavigne, R.; Brüssow, H. Bacteriophage Therapy: Advances 
in Formulation Strategies and Human Clinical Trial. Annu. Rev. Virol. 2015, 2, 
599–618, doi:10.1146/annurev-virology-100114-054915. 
14. García, P.; Rodríguez-Rubio, L.; Rodríguez, A.; Martínez, B. Food 
biopreservation: Promising strategies using bacteriocins, bacteriophages and 
endolysins. Trends Food Sci. Technol. 2010, 21, 373–382; 
DOI:10.1016/j.tifs.2010.04.010. 
15. Aminov, R.; Caplin, J.; Chanishvili, N.; Coﬀey, A.; Cooper, I.; de Vos, D.; Doška, 
J.R.; Friman, V.P.; Kurtböke, I.; Pantůček, R.; et al. Application of 
bacteriophages. Microbiol. Aust. 2017, 38, 63–66, doi:10.1071/MA17029. 
16. Gutiérrez, D.; Vandenheuvel, D.; Martínez, B.; Rodríguez, A.; Lavigne, R.; 
García, P. Two Phages, phiIPLA-RODI and phiIPLA-C1C, lyse mono- and 
dual-species staphylococcal biofilms. Appl. Environ. Microbiol. 2015, 81, 3336–
3348, doi:10.1128/AEM.03560-14. 
17. Kelly, D.; McAuliffe, O.; Ross, R.P.; Coffey, A. Prevention of Staphylococcus 
aureus biofilm formation and reduction in established biofilm density using a 
combination of phage K and modified derivatives. Lett. Appl. Microbiol. 2012, 54, 
286–291, doi:10.1111/j.1472-765X.2012.03205.x. 
18. Alves, D.R.; Gaudion, A.; Bean, J.E.; Perez Esteban, P.; Arnot, T.C.; Harper, 
D.R.; Kot, W.; Hansen, L.H.; Enright, M.C.; Jenkins, A.T. Combined use of 
bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus 
biofilm formation. Appl. Environ. Microbiol. 2014, 80, 6694–6703, 
doi:10.1128/AEM.01789-14. 
19. Lu, T.K.; Bowers, J.; Koeris, M.S. Advancing bacteriophage-based microbial 
diagnostics with synthetic biology. Trends Biotechnol. 2013, 31, 325–327, 
doi:10.1016/j.tibtech.2013.03.009. 
20. Warner, C.M.; Barker, N.; Lee, S.W.; Perkins, E.J. M13 bacteriophage 
production for large-scale applications. Bioprocess Biosyst. Eng. 2014, 37, 
2067–2072, doi:10.1007/s00449-014-1184-7. 
21. Montgomery, D.C. Design and Analysis of Experiments, 9th ed.; John Wiley & 
Sons, Inc.: New York, NY, USA, 2017; pp. 489–568, ISBN: 978-1-119-11347-8. 
22. Myers, R.H.; Montgomery, D.C.; Anderson-Cook, C.M. Multiple Response 
Optimization. In Response Surface Methodology Process and Product 
Optimization Using Designed Experiments, 4th ed.; John Wiley & Sons, Inc.: 
Hoboken, NJ, USA, 2016; pp. 325–368, ISBN 978-1-118-91601-8. 
23. Grieco, S.H.; Wong, A.Y.; Dunbar, W.S.; MacGillivray, R.T.; Curtis, S.B. 
Optimization of fermentation parameters in phage production using response 
surface methodology. J. Ind. Microbiol. Biotechnol. 2012, 39, 1515–1522, 
doi:10.1007/s10295-012-1148-3. 
24. Gutierrez, D.; Delgado, S.; Vazquez-Sanchez, D.; Martinez, B.; Cabo, M.L.; 
Rodriguez, A.; Herrera, J.J.; Garcia, P. Incidence of Staphylococcus aureus and 
 analysis of associated bacterial communities on food industry surfaces. Appl. 
Environ. Microbiol. 2012, 8, 8547–8554, doi:10.1128/AEM.02045-12. 
25. Gutiérrez, D.; Ruas-Madiedo, P.; Martínez, B.; Rodríguez, A.; García, P. 
Effective removal of staphylococcal biofilms by the endolysin LysH5. PLoS ONE 
2014, 9, e107307, doi:10.1128/AEM.00018-12. 
26. Gutiérrez, D.; Martínez, B.; Rodríguez, A.; García, P. Isolation and 
characterization of bacteriophages infecting Staphylococcus epidermidis. Curr. 
Microbiol. 2010, 61, 601–608, doi:10.1007/s00284-010-9659-5. 
27. Myers, R.H.; Montgomery, D.C. Response surface methodology, 2nd ed.; John 
Wiley & Sons, Inc.: New York, NY, USA, 2002. 
28. Pirnay, J.P.; Blasdel, B.G. Bretaudeau, L.; Buckling, A.; Chanishvili, N.; Clark, 
J.R.; Corte-Real, S.; Debarbieux, L.; Dublanchet, A.; De Vos, D.; et al. Quality 
and safety requirements for sustainable phage therapy products. Pharm. Res. 
2015, 32, 2173–2179, doi:10.1007/s11095-014-1617-7. 
29. Santos, S.B.; Fernandes, E.; Carvalho, C.M.; Sillankorva, S.; Krylov, V.N.; 
Pleteneva, E.A.; Shaburova, O.V.; Nicolau, A.; Ferreira, E.C.; Azeredo, J. 
Selection and characterization of a multivalent Salmonella phage and its 
production in a nonpathogenic Escherichia coli strain. Appl. Environ. Microbiol. 
2010, 76, 7338–7342, doi:10.1128/AEM.00922-10. 
30. El Haddad, L.; Ben Abdallah, N.; Plante, P.L.; Dumaresq, J.; Katsarava, R.; 
Labrie, S.; Corbeil, J.; St-Gelais, D.; Moineau, S. Improving the safety of 
Staphylococcus aureus polyvalent phages by their production on a 
Staphylococcus xylosus strain. PLoS ONE 2014, 9, e102600, 
doi:10.1371/journal.pone.0102600. 
31. Hyman, P.; Abedon, S.T. Practical methods for determining phage growth 
parameters. Methods Mol. Biol. 2009, 501, 175–202, 
doi:10.1007/978-1-60327-164-6_18. 
32. Santos, S.B.; Carvalho, C.; Azeredo, J.; Ferreira, E.C. Population dynamics of a 
Salmonella lytic phage and its host: Implications of the host bacterial growth rate 
in modelling. PLoS ONE 2014, 9, e102507, doi:10.1371/journal.pone.0136007. 
33. Denes, T.; Wiedmann, M. Environmental responses and phage susceptibility in 
foodborne pathogens: Implications for improving applications in food safety. 
Curr. Opin. Biotechnol. 2014, 26, 45–49, doi:10.1016/j.copbio.2013.09.001. 
34. Bryan, D.; El-Shibiny, A.; Hobbs, Z.; Porter, J.; Kutter, E.M. Bacteriophage T4 
Infection of stationary phase E. coli: Life after log from a phage perspective. 
Front. Microbiol. 2016, 7, 1391, doi:10.3389/fmicb.2016.01391. 
35. Kasman, L.M.; Kasman, A.; Westwater, C.; Dolan, J.; Schmidt, M.G.; Norris, J.S. 
Overcoming the phage replication threshold: A mathematical model with 
implications for phage therapy. J. Virol. 2002, 76, 5557–5564, 
doi:10.1128/JVI.76.11.5557-5564.2002. 
36. Payne, R.J.; Jansen, V.A. Pharmacokinetic principles of bacteriophage therapy. 
Clin. Pharmacokinet. 2003, 42, 315–325, 
doi:10.2165/00003088-200342040-00002. 
© 2018 by the authors. Submitted for possible open access publication under the 
terms and conditions of the Creative Commons Attribution (CC BY) license 
(http://creativecommons.org/licenses/by/4.0/). 
 
 
 Table S1. Efficiencies of plaque formation (EOP) of phage phiIPLA-RODI propagated on S. aureus 
IPLA1 (A) and S. xylosus CTC1642 (B), on different sensitive strains. 
Specie Strain Origin References EOPa 
A B 
S. aureus 
IPLA1b Dairy industry surfaces 24 1.00 ± 0.10 1.00 ± 0.20 
IPLA15 Meat industry surfaces 24 0.29 ± 0.18 0.31 ± 0.10 
IPLA16 Meat industry surfaces 24 1.33 ± 0.29 0.99 ± 0.4 
S. lugdunensis ZL5-11 Women’s breast milk 16 1.02 ± 0.35 1.30 ± 0.20 
S. pasteuri ZL16-6 Women’s breast milk 16 0.33 ± 0.05 0.53 ± 0.22 
S. arlettae ZL114-5 Women’s breast milk 16 0.37 ± 0.06 0.54 ± 0.06 
S. xylosus ZL61-2 Women’s breast milk 16 0.09 ± 0.04 0.10 ± 0.03 
S. gallinarum ZL90-5 Women’s breast milk 16 0.38 ± 0.09 0.27 ± 0.05 
S. kloosii ZL74-2 Women’s breast milk 16 0.50 ± 0.18 0.30 ± 0.02 
a Means and standard deviations were calculated from three biological replicates. 
b The reference strain used for the EOP calculations. 
 
 
  
  
 
 
 
 
 
 
 
 
Figure S1. Bacteriophage mediated removal of 24 h-old biofilms of S. aureus IPLA16. 
Biofilms were treated with phage phiIPLA-RODI propagated on S. aureus IPLA1 (dark grey) 
and on S. xylosus CTC1642 (light grey). Control biofilms are shown in black. Biomass was 
calculated by crystal violet staining of adhered cells after phage treatment (test samples) 
and without phage treatment (control samples). Absorbance was measured at a wavelength 
of 595 nm. Means and standard deviations were calculated from three biological replicates. 
Bars having different letters are significantly different (ANOVA; P<0.05). 
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